Abstract:Cellobiose 2-epimerase (CE) is commonly recognized as an epimerase as most CEs mainly exhibit an epimerization activity towards disaccharides. In recent years, several CEs have been found to possess bifunctional epimerization and isomerization activities. They can convert lactose into lactulose, a high-value disaccharide that is widely used in the food and pharmaceutical industries. However, the factors that determine the catalytic direction in CEs are still not clear. In this study, the crystal structures of three newly discovered CEs, CsCE (a bifunctional CE from Caldicellulosiruptor saccharolyticus), StCE (a bifunctional CE from Spirochaeta thermophila DSM 6578) and BtCE (a monofunctional CE from Bacillus thermoamylovorans B4166), were determined at 1.54, 2.05 and 1.80 Å resolution, respectively, in order to search for structural clues to their monofunctional/bifunctional properties. A comparative analysis of the hydrogen-bond networks in the active pockets of diverse CEs, YihS and mannose isomerase suggested that the histidine corresponding to His188 in CsCE is uniquely required to catalyse isomerization. By alignment of the apo and ligand-bound structures of diverse CEs, it was found that bifunctional CEs tend to have more flexible loops and a larger entrance around the active site, and that the flexible loop 148-181 in CsCE displays obvious conformational changes during ligand binding. It was speculated that the reconstructed molecular interactions of the flexible loop during ligand binding helped to motivate the ligands to stretch in a manner beneficial for isomerization. Further site-directed mutagenesis analysis of the flexible loop in CsCE indicated that the residue composition of the flexible loop did not greatly impact epimerization but affects isomerization. In particular, V177D and I178D mutants showed a 50% and 80% increase in isomerization activity over the wild type. This study provides new information about the structural characteristics involved in the catalytic properties of CEs, which can be used to guide future molecular modifications.

Uncovering Biphasic Catalytic Mode of C 5 -Epimerase in Heparan Sulfate Biosynthesis

Altered architecture of substrate binding region defines the unique specificity of UDP-GalNAc 4-epimerases

Interacting polymer-modification enzymes in heparan sulfate biosynthesis

"Coding" and "decoding": Hypothesis for the Regulatory Mechanism Involved in Heparan Sulfate Biosynthesis.

Structural and mechanistic characterization of bifunctional heparan sulfate N-deacetylase-N-sulfotransferase 1

Chemoenzymatic synthesis of heparan sulfate and heparin

Concise Chemoenzymatic Synthesis of Heparan Sulfate Analogues As Potent BACE-1 Inhibitors.

Understanding the Substrate Specificity of the Heparan Sulfate Sulfotransferases by an Integrated Biosynthetic and Crystallographic Approach

Investigation of the biological functions of heparan sulfate using a chemoenzymatic synthetic approach

Catalytic Mechanism of Heparinase II Investigated by Site-directed Mutagenesis and the Crystal Structure with Its Substrate*

Synthesis of a S-linked heparan sulfate trisaccharide as the substrate mimic of heparanase

Molecular Mechanism of Substrate Specificity for Heparan Sulfate 2-O-sulfotransferase

Insight into the Potential Factors Influencing the Catalytic Direction in Cellobiose 2-Epimerase by Crystallization and Mutagenesis.

Probing cleavage promiscuity of heparinase III towards chemoenzymatically synthetic heparan sulfate oligosaccharides.

1H NMR Analysis of Perdeutero N-sulfoheparosan C5-epimerization: a Direct Way to Measure the Activity of Immobilized C5-epimerase

Direct C5‐Isomerization Approach to L‐iduronic Acid Derivatives

Molecular mechanism of decision-making in glycosaminoglycan biosynthesis

Expanding the Catalytic Promiscuity of Heparinase III from Pedobacter Heparinus.

Dermatan sulfate epimerase 1 and dermatan 4- O-sulfotransferase 1 form complexes that generate long epimerized 4- O-sulfated blocks

Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate

Using Engineered 6-O-sulfotransferase to Improve the Synthesis of Anticoagulant Heparin